In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R21 Clinical Trial Not Allowed) | RFA DE 23 005

Opportunity Information: Apply for RFA DE 23 005

The funding opportunity titled "In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R21 Clinical Trial Not Allowed)" (RFA-DE-23-005) is a National Institutes of Health (NIH) discretionary grant program aimed at speeding up early-stage, exploratory research on fetal (in utero) interventions for congenital conditions affecting the teeth, jaws, face, and related craniofacial structures. The core idea is to use animal models alongside precision medicine strategies to design and test potential prenatal treatments, with the longer-term objective of building the scientific foundation needed to eventually deliver safe and effective in utero therapies in humans. Because this is an R21 mechanism, the emphasis is generally on innovative, high-impact concepts and proof-of-concept studies rather than large, definitive programs, and the announcement explicitly states that clinical trials are not allowed under this opportunity.

The scientific focus is on congenital dental and craniofacial disorders, which are conditions present before birth that can disrupt normal development of craniofacial tissues. The initiative encourages the use of precision medicine approaches, meaning applicants are expected to consider biological variability and disease mechanisms at a more individualized or mechanism-driven level. In practice, that often points toward research designs that link genotype to phenotype, stratify disease subtypes, or leverage molecular and developmental information to tailor a therapeutic approach. The use of animal models is central, indicating that proposed studies should be conducted in relevant preclinical systems where fetal development can be observed and manipulated, and where prenatal delivery routes, timing, dosing, safety, and developmental outcomes can be evaluated. The stated intent is not simply to study these disorders, but to accelerate the development of treatment strategies that could plausibly be translated to prenatal care in the future.

Administratively, this opportunity is a grant (Funding Instrument Type: Grant) in the health area (Funding Activity Category: Health) and is associated with CFDA number 93.121. It was created on 2022-02-16, with an original closing date listed as 2022-06-14. The source information provided does not specify an award ceiling or the expected number of awards, so applicants would typically need to consult the full funding announcement or NIH budget guidance for the R21 mechanism to understand typical budget ranges, project period expectations, and any institute-specific constraints.

Eligibility is broad and includes many types of U.S.-based and certain non-U.S. organizations. Eligible applicants include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education, based on the listing); for-profit organizations other than small businesses; small businesses; and additional unspecified "other" entities. The announcement also explicitly highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible agencies of the federal government, regional organizations, U.S. territories or possessions, Indian/Native American tribal governments other than federally recognized, and non-domestic (non-U.S.) entities (foreign organizations). Taken together, this means the program is designed to draw participation from a wide range of research performers and community-relevant institutions, including those serving historically underrepresented populations and those located outside the continental United States.

In practical terms, a strong application under this announcement would be expected to propose a clear, biologically grounded prenatal intervention concept for a congenital dental or craniofacial condition, justify the choice of animal model(s), and explain how precision medicine elements (for example, molecular targeting, mechanistic stratification, or genotype-informed treatment design) improve the likelihood of meaningful translation. Since clinical trials are not allowed, the work should remain preclinical, focusing on the kinds of data needed to de-risk future human translation, such as feasibility of fetal delivery, developmental timing, safety signals, durability of effect, and measurable improvements in craniofacial or dental developmental outcomes in the model system.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121.
• This funding opportunity was created on 2022-02-16.
• Applicants must submit their applications by 2022-06-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DE 23 005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: